Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients

NCT00521885 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study stopped due to lack of accrual

Conditions

Venous Thrombosis

Interventions

DRUG: Arixtra (Fondaparinox) 2.5 mg SC Daily
DRUG: Lovenox 40mg SC Daily

Sponsor

Lehigh Valley Hospital

Collaborators

[object Object]